Negative ANXA1 expression was also a poor prognostic indicator in pancreatic ductal adenocarcinoma, and showed a direct role in enhancing tumor aggressiveness in prostate cancer [72, 73]. The gene discussed is ANXA1; the disease is pancreatic ductal adenocarcinoma.